ALPMY - 3 Things In Biotech You Should Learn Today: January 25 2018
Note: Subscribers to Avisol Capital Partners' Total Pharma Tracker got an early look at this publication. Consider becoming a subscriber today to get early access!
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.
Novartis looks to more compassionate use outside the US
Company: Genmab (GNMSF) and Novartis (NVS)
Therapy: Ofatumumab
Disease: Chronic lymphocytic leukemia
News: GNMSF announced that it has recognized $50 million in compensation for potential lost